Childhood-Onset Lupus Nephritis Linked With Adverse Outcomes
Early diagnosis and treatment of childhood-onset systemic lupus erythematosus is important to prevent lupus nephritis outcomes such as end-stage kidney disease.
Diagnosis & Disease Information
Lupus Nephritis Remission Predicted by Artificial Neural Network
With further validation, the artificial neural network may be used in clinical practice for lupus nephritis management.
ACR: Low-Dose Hydroxychloroquine Tied to More Hospitalizations for Lupus Flares
Both weight-based and non-weight-based low-dose HCQ associated with increased hospitalizations for SLE
Belimumab Efficacy for Lupus Nephritis Maintained Beyond 2 Years
Belimumab treatment continued to protect the kidneys in adults with active lupus nephritis.
Lupus Nephritis Drug Voclosporin Shows Efficacy, Safety Over 3 Years
One study focused on patients with severe lupus nephritis, who are at greatest risk for kidney failure.
Lupus Anticoagulant Levels May Predict Cardiac Dysfunction in Patients With SLE
In a 5-year follow-up study, researchers identified the characteristics associated with cardiac function in patients with systemic lupus erythematosus.
SLE Flare Can Still Occur After Dialysis Initiation
In a study of 121 patients with lupus nephritis on dialysis, 26.4% experienced an SLE flare at a median of 17 months after dialysis initiation.
Incident Cardiovascular Disease Risk Up With Autoimmune Disease
Risk increased progressively with the number of autoimmune diseases present and with younger age
GAPSS Outperforms QRISK in Assessing Cardiovascular Disease Risk in Patients With SLE
Researchers compared the QRISK3 and the adjusted Global AntiPhospholipid Syndrome Score in patients with systemic lupus erythematosus to assess their risk of developing cardiovascular disease.
Reduction in Swollen, Tender Joints Greater With Litifilimab in Lupus
Most secondary end points did not support the results of the analysis for the primary end point
- Loading...
Loading...
Next post in Lupus Nephritis
Loading... 
Loading...